Skip to main content

Living with Precocious Puberty in Children?

Discover Hope Through Pediatric Clinical Trials

Precocious puberty is when a child’s body begins developing too early, usually before age 8 in girls and age 9 in boys. This early activation of puberty can cause rapid bone growth, advanced sexual development, emotional challenges, and potential long-term health risks.

The most common form, central precocious puberty (CPP), happens when the brain signals the body to start puberty too soon. Left untreated, it may lead to shorter adult height, bone health issues, and significant psychological stress for children and families.

Revival Research Institute is conducting Precocious Puberty Clinical Trials to explore innovative treatment options. These studies aim to assess the safety and efficacy of investigational therapies that could potentially slow down puberty, helping children grow at a healthier pace while supporting their overall well-being.

Are You Eligible to Participate?

To participate in our clinical trial for early puberty in children, individuals must meet the following criteria:

  • Children, girls up to 8 years of age and boys up to 9 years of age.
  • Diagnosed with central precocious puberty
  • Onset of development of sex characteristics

*Additional Criteria may apply

Participation in precocious puberty clinical trials in Texas or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

"*" indicates required fields

Who is this information for?**

Please provide YOUR contact information only.

Name*
Best Time to Call*
User Agreement*

This is our Privacy Policy.

This field is for validation purposes and should be left unchanged.
Precocious Puberty Clinical Trials Flyer

About the Clinical Trials for Precocious Puberty

Early puberty can be emotionally and physically challenging for children and families. It often brings unexpected changes that may affect a child’s confidence and overall well-being. Parents may also feel concerned or uncertain about how to best support their child during this rapid stage of development.

Revival Research Institute is conducting a clinical research study to evaluate the safety and effectiveness of an investigational treatment for children experiencing early puberty.

Precocious Puberty Clinical Trials will be conducted in several locations across the United States, including Texas. To ensure study eligibility, all participants must comply with all study procedures. Participants who meet the eligibility criteria after undergoing the screening phase and are chosen to participate will be given the placebo or study treatment.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If your child is experiencing early puberty, they may qualify for a clinical trial focused on potential treatment options for this condition. After completing the interest form above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation helps advance future treatments for early puberty.

Age

5 to 9 years of age

Condition

Central Precocious Puberty (CPP)

Location

Texas

Understanding Early Puberty in Children

Understanding Early Puberty in Children

Early puberty can be caused by:

  • Pituitary tumors or surgery
  • Traumatic brain injury
  • Radiation therapy
  • Autoimmune inflammation
  • Idiopathic causes (no known cause)

Symptoms of early puberty include:

  • Early breast or testicular development
  • Rapid growth or advanced bone age
  • Early menstruation in girls
  • Mood swings, emotional challenges, and social stress
  • Shorter predicted adult height

The primary treatment for precocious puberty involves hormone therapy designed to suppress puberty until a more appropriate age. Participation in Clinical Trials for early puberty can provide access to investigational treatments aimed at improving health outcomes.

Frequently Asked Questions (FAQs)

What is precocious puberty?

Precocious puberty occurs when puberty begins too early, before age 8 in girls and 9 in boys. Central precocious puberty is caused by premature activation of the brain-pituitary-gonadal axis.

Can early puberty be stopped?

Yes, certain hormone treatments can help pause or delay puberty until the child reaches a normal age for development. Clinical trials are testing new therapies to improve these outcomes.

What happens if precocious puberty is not treated?

Without treatment, children may stop growing too early, resulting in shorter adult height. Emotional and social challenges may also arise.

How is precocious puberty diagnosed?

Diagnosis usually involves a physical exam, hormone level testing, bone age X-rays, and sometimes brain imaging to identify the cause.

Why should my child participate in a clinical trial?

By enrolling in a precocious puberty clinical trial, your child may access investigational treatment at no cost, receive care from pediatric specialists, and help advance future therapies for CPP and pediatric endocrinology.

Close Menu







    Your information is confidential and used only for study enrollment purposes.








      Your information is confidential and used only for study enrollment purposes.








        Your information is confidential and used only for study enrollment purposes